Evaluation of 99mTc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 10, 2015, Pages 923-928

  Carlesso, F N ^a   Fuscaldi, L L ^a   Araujo R S ^a   Teixeira, C S ^a   Oliveira, M C ^a   Fernandes, S O A ^a   Cassali, G D ^a   Reis, D C ^a   Barros, A L B ^a   Cardoso, V N ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

99mTc HYNIC Ala Bombesin; Biodistribution; Capan 1; Pancreas tumor; Scintigraphic images

Indexed keywords

2 HYDRAZINONICOTINAMIDE BETA ALANINE BOMBESIN TC 99M; GASTRIN RELEASING PEPTIDE RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; BOMBESIN; GASTRIN RELEASING PEPTIDE; PEPTIDE FRAGMENT; TECHNETIUM 99M HYNIC-BETA-ALA-BOMBESIN(7-14); TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER INCIDENCE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHYSICAL PARAMETERS; PROTEIN EXPRESSION; RADIOACTIVITY; RADIODIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTIGRAPHY; THIN LAYER CHROMATOGRAPHY; TUMOR GROWTH; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; ANIMAL; DIAGNOSTIC IMAGING; MUSCLE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; SCINTISCANNING; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BOMBESIN; CELL LINE, TUMOR; GASTRIN-RELEASING PEPTIDE; HETEROGRAFTS; HUMANS; MALE; MICE, NUDE; MUSCLES; ORGANOTECHNETIUM COMPOUNDS; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; RADIONUCLIDE IMAGING;

EID: 84943641488     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20154506     Document Type: Article

References (26)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al.Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer 2015; 136: E359-E386, doi: 10.1002/ijc.29210.
2. Schottelius M, Wester HJ.Molecular imaging targeting peptide receptors.Methods 2009; 48: 161-177, doi: 10.1016/j.ymeth.2009.03.012.
3. Ferro-Flores G, Ramirez FM, Melendez-Alafort L, Santos-Cuevas CL.Peptides for in vivo target-specific cancer imaging.Mini Rev Med Chem 2010; 10: 87-97, doi: 10.2174/138955710791112596.
4. Fani M, Maecke HR, Okarvi SM.Radiolabeled peptides: valuable tools for the detection and treatment of cancer.Theranostics 2012; 2: 481-501, doi: 10.7150/thno.4024.
5. Laverman P, Sosabowski JK, Boerman OC, Oyen WJ.Radiolabelled peptides for oncological diagnosis.Eur J Nucl Med Mol Imaging.2012; 39 (Suppl 1)S78-S92, doi: 10.1007/s00259-011-2014-7.
6. De Barros ALB, Mota LG, Soares DCF, Coelho MMA, Oliveira MC, Cardoso VN.Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification.Bioorg Med Chem Lett 2011; 21: 7373-7375, doi: 10.1016/j.bmcl.2011.10.016.
7. Yu Z, Carlucci G, Ananias HJ, Dierckx RA, Liu S, Helfrich W, et al.Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.Amino Acids 2013; 44: 543-553, doi: 10.1007/s00726-012-1369-9.
8. Accardo A, Aloj L, Aurilio M, Morelli G, Tesauro D.Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs.Int J Nanomedicine 2014; 9: 1537-1557, doi: 10.2147/ijn.s53593.
9. Schroeder RP, Van Weerden WM, Bangma C, Krenning EP, De Jong M.Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.Methods 2009; 48: 200-204, doi: 10.1016/j.ymeth.2009.04.002.
10. Lears KA, Ferdani R, Liang K, Zheleznyak A, Andrews R, Sherman CD, et al.In vitro.and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrinreleasing peptide receptor-expressing prostate cancer.J Nucl Med 2011; 52: 470-477, doi: 10.2967/jnumed.110.082826.
11. Fani M, Maecke HR.Radiopharmaceutical development of radiolabelled peptides.Eur J Nucl Med Mol Imaging.2012; 39 (Suppl 1): S11-S30, doi: 10.1007/s00259-011-2001-z.
12. Kong FL, Zhang Y, Young DP, Yu DF, Yang DJ.Development of (99m)Tc-EC-tyrosine for early detection of breast cancer tumor response to the anticancer drug melphalan.Acad Radiol 2013; 20: 41-51, doi: 10.1016/j.acra.2012.08.005.
13. 99mTc via hydrazinonicotinamide: description of optimized radiolabeling conditions.J Radioanal Nucl Chem 2010; 284: 539-545, doi: 10.1007/s10967-010-0530-8.
14. Lambrecht FY, Durkan K, Özgür A, Gündüz C, Avcý ÇB, Susluer SY.In vitro.evaluation of 99mTc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.J Drug Target 2013; 21: 383-388, doi: 10.3109/1061186x.2012.757772.
15. Kyriazis AP, Kyriazis AA, Scarpelli DG, Fogh J, Rao MS, Lepera R.Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics.Am J Pathol 1982; 106: 250-260.
16. Burghardt B, Wenger C, Barabas K, Racz G, Olah A, Flautner L, et al.GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF.Peptides 2001; 22: 1119-1128, doi: 10.1016/s0196-9781(01)00433-8.
17. Schally AV, Szepeshazi K, Nagy A, Comaru-Schally AM, Halmos G.New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.Cell Mol Life Sci 2004; 61: 1042-1068, doi: 10.1007/s00018-004-3434-3.
18. Szepeshazi K, Schally AV, Nagy A, Halmos G.Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog.Pancreas 2005; 31: 275-282, doi: 10.1097/01.mpa.0000175892.97036.a7.
19. De Barros ALB, Mota LG, Ferreira CA, Oliveira MC, Goes AM, Cardoso VN.Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification.Bioorg Med Chem Lett 2010; 20: 6182-6184, doi: 10.1016/j.bmcl.2010.08.124.
20. (7-14).Appl Radiat Isot 2012; 70: 2440-2445, doi: 10.1016/j.apradiso.2012.06.022.
21. (7-14) in an experimental model.J Radioanal Nucl Ch 2014; 300: 801-807, doi: 10.1007/s10967-014-3040-2.
22. Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.Nucl Med Biol 2008; 35: 401-411, doi: 10.1016/j.nucmedbio.2008.02.005.
23. Phillips WT.Delivery of gamma-imaging agents by liposomes.Adv Drug Deliv Rev 1999; 37: 13-32, doi: 10.1016/s0169-409x(98)00108-2.
24. 99mTc-labeled bombesin analog for breast cancer identification.J Radioanal Nucl Chem 2013; 295: 2083-2090, doi: 10.1007/s10967-012-2331-8.
25. (7-14)NH2 with favorable properties for SPECT imaging of colon cancer.Bioconjug Chem 2008; 19: 1170-1178, doi: 10.1021/bc700471z.
26. Larghi A, Verna EC, Lecca PG, Costamagna G.Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.Clin Cancer Res 2009; 15: 1907-1914, doi: 10.1158/1078-0432.ccr-08-1966.